Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
-
July
-
August
- September -
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
-
2016
- 2017 -
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
September 2017 - 56 products
L
IP
Refixia 3000 IE
5336.28
5516.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 3000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Zytiga 500 mg
56
2276.07
2406.15
20 %
Coated tablets: Abirateroni Acetas 500 mg
Janssen-Cilag AG
B / SL / SO
FB
G
IP
CI
Travo-Vision 40mcg/ml
2.5 ml
9.93
27.20
10 %
Eye drops: Travoprostum 40 µg/ml
OmniVision AG
● 
B / SL / SG
FB
G
IP
CI
Travo-Vision 40mcg/ml
3 x 2.5 ml
28.30
47.20
10 %
Eye drops: Travoprostum 40 µg/ml
OmniVision AG
● 
B / SL / SG
FB
G
L
IP
Pemetrexed-Teva liquid 100 mg / 4 ml
85.10
108.95
10 %
Concentrate for infusion: Pemetrexedum 100mg / 4ml
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Pemetrexed-Teva liquid 500 mg / 20 ml
425.50
479.15
10 %
Concentrate for infusion: Pemetrexedum 500mg / 20ml
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Pemetrexed-Teva liquid
1000 mg / 40 ml
851.00
941.95
10 %
Concentrate for infusion: Pemetrexedum 1000mg / 40ml
Teva Pharma AG
A / SL / SG
FB
G
L
IP
Pemetrexed-Teva liquid 850 mg / 34 ml
723.35
803.10
10 %
Concentrate for infusion: Pemetrexedum 850mg / 34ml
Teva Pharma AG
A / SL / SG
FB
G
IP
Atazanavir-Mepha 200mg
60
353.72
401.10
10 %
Capsules: Atazanavirum 200 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
Atazanavir-Mepha 300mg
30
353.72
401.10
10 %
Capsules: Atazanavirum 300 mg
Mepha Pharma AG
A / SL / SG
FB
G
IP
CI
Dutasterid Spirig HC
0.5mg
30
5.47
15.15
10 %
Soft capsules: Dutasteridum
Spirig HealthCare AG
● 
B / SL / SG
FB
G
IP
CI
Dutasterid Spirig HC
0.5mg
90
16.47
34.30
10 %
Soft capsules: Dutasteridum
Spirig HealthCare AG
● 
B / SL / SG
FB
G
L
IP
CI
PP
Maviret Filmtabletten
84
14407.03
15089.40
10 %
2 Active Agents
AbbVie AG
A / SL
FB
G
L
IP
PP
Parsabiv 2.5 mg
6
93.72
118.35
10 %
Injection solution: Etelcalcetidum 2.5 mg
Amgen Switzerland AG
B / SL
FB
G
L
IP
PP
Parsabiv 5.0 mg
6
161.20
191.75
10 %
Injection solution: Etelcalcetidum 5 mg
Amgen Switzerland AG
B / SL
FB
G
L
IP
PP
Parsabiv 10.0 mg
6
281.17
322.20
10 %
Injection solution: Etelcalcetidum 10 mg
Amgen Switzerland AG
B / SL
FB
G
L
IP
CI
Refixia 500 IE
889.38
953.55
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 500 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 1000 IE
1778.76
1866.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 1000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
CI
Refixia 2000 IE
3557.52
3691.05
10 %
Lyophilisate and solvent: Nonacogum beta Pegolum 2000 UI
Novo Nordisk Pharma AG
B / SL
FB
G
L
IP
Bavencio 200 mg/10 ml
827.76
916.65
10 %
Concentrate for infusion: Avelumabum 200mg / 10ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Bavencio 200 mg/10 ml
4
3311.04
3617.35
10 %
Concentrate for infusion: Avelumabum 200mg / 10ml
Merck (Schweiz) AG
A / SL
FB
G
L
IP
Ocrevus
5324.47
5770.70
10 %
Concentrate for infusion: Ocrelizumabum 300mg / 10ml
Roche Pharma
(Schweiz) AG
A / SL
FB
G
L
IP
CI
Intuniv 1 mg
7
17.74
35.70
10 %
Delayed release tablets: Guanfacinum 1 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 1 mg
28
70.92
93.55
10 %
Delayed release tablets: Guanfacinum 1 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 2 mg
7
18.10
36.10
10 %
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 2 mg
28
72.41
95.15
10 %
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 3 mg
28
75.76
98.80
10 %
Delayed release tablets: Guanfacinum 3 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
Intuniv 4 mg
28
81.66
105.25
10 %
Delayed release tablets: Guanfacinum 4 mg
Takeda Pharma AG
B / SL
FB
G
L
IP
CI
PP
Spinraza 12mg/5ml
5 ml
78390.18
80736.10
10 %
Lösung zur intrathekalen Injektion: Nusinersenum 12mg / 5ml
Biogen Switzerland AG
A / SL
FB
G
IP
Intuniv 2 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 2 mg
Takeda Pharma AG
B
FB
G
IP
Intuniv 3 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 3 mg
Takeda Pharma AG
B
FB
G
IP
Intuniv 4 mg
84
PR
PR
k.A.
Delayed release tablets: Guanfacinum 4 mg
Takeda Pharma AG
B
FB
G
IP
CI
Tadalafil axapharm 2.5mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 2.5 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 5mg
12
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 5mg
28
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 5mg
84
PR
PR
k.A.
Coated tablets: Tadalafilum 5 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 10mg
4
PR
PR
k.A.
Coated tablets: Tadalafilum 10 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 10mg
12
PR
PR
k.A.
Coated tablets: Tadalafilum 10 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 20mg
4
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 20mg
8
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 20mg
12
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
axapharm ag
B
FB
G
IP
Tadalafil axapharm 20mg
24
PR
PR
k.A.
Coated tablets: Tadalafilum 20 mg
axapharm ag
B
FB
G
IP
CI
Atazanavir-Mepha 150mg
60
PR
PR
k.A.
Capsules: Atazanavirum 150 mg
Mepha Pharma AG
A
FB
G
CI
H
Adler Ferruplex
400
PR
PR
k.A.
Tablets: 6 Active Agents
Adler Pharma Helvetia AG
D
FB
G
CI
H
Adler Ferruplex
1000
PR
PR
k.A.
Tablets: 6 Active Agents
Adler Pharma Helvetia AG
D
FB
G
CI
H
Adler Vita
400
PR
PR
k.A.
Tablets: 5 Active Agents
Adler Pharma Helvetia AG
D
FB
G
CI
H
Adler Vita
1000
PR
PR
k.A.
Tablets: 5 Active Agents
Adler Pharma Helvetia AG
D
FB
G
IP
CM
HEMONITA D3 zur
Prophylaxe
10 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
D
FB
G
IP
CM
HEMONITA D3 zur
Prophylaxe
20 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
D
FB
G
IP
CM
HEMONITA D3 zur Therapie
30 ml
PR
PR
k.A.
Solution (oral): Cholecalciferolum 4000 UI/ml
Hemony Pharmaceutical
Switzerland GmbH
B
FB
G
IP
CI
Recofol EDTA 10mg/ml
50 ml
PR
PR
k.A.
Emulsion zur Injektion/Infusion: Propofolum 10 mg
Primex
Pharmaceuticals AG
B
FB
G
IP
CI
Recofol EDTA 10mg/ml
5 x 20 ml
PR
PR
k.A.
Emulsion zur Injektion/Infusion: Propofolum 10 mg
Primex
Pharmaceuticals AG
B
FB
G
IP
CI
Recofol EDTA 10mg/ml
5 x 20 ml
PR
PR
k.A.
Emulsion zur Injektion/Infusion: Propofolum 10 mg
Primex
Pharmaceuticals AG
B
FB
G
IP
CI
Recofol EDTA 10mg/ml
100 ml
PR
PR
k.A.
Emulsion zur Injektion/Infusion: Propofolum 10 mg
Primex
Pharmaceuticals AG
B
FB
G
IP
CI
Algifor Dolo forte 200 mg / 5 ml
100 ml
PR
PR
k.A.
Suspension: Ibuprofenum 200 mg
VERFORA SA
D
FB
G
IP
CI
Algifor Dolo forte 400 mg / 10 ml
10 ml
PR
PR
k.A.
Suspension: Ibuprofenum 400 mg
VERFORA SA
D
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home